2011
DOI: 10.1111/j.1442-9071.2011.02558.x
|View full text |Cite
|
Sign up to set email alerts
|

Geldanamycin is effective in the treatment of herpes simplex virus epithelial keratitis in a rabbit model

Abstract: Geldanamycin is a promising treatment option against herpes simplex virus type 1 epithelial keratitis. Geldanamycin (10 µg/mL) is better than acyclovir and geldanamycin (5 µg/mL) in the rabbit model. The optimal concentration of this drug in human is still to be determined.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Jiang Han Plain, with high precipitation, humid climate, rich vegetation, and dense distribution of water resource, which was a favourable environment for fungal growth. Corneal plant injury was more common due to the predominantly agricultural population, but the economic conditions were relatively low, resulting in relatively backward timeliness and accuracy of diagnosis and treatment [7].…”
Section: Discussionmentioning
confidence: 99%
“…Jiang Han Plain, with high precipitation, humid climate, rich vegetation, and dense distribution of water resource, which was a favourable environment for fungal growth. Corneal plant injury was more common due to the predominantly agricultural population, but the economic conditions were relatively low, resulting in relatively backward timeliness and accuracy of diagnosis and treatment [7].…”
Section: Discussionmentioning
confidence: 99%
“…In vivo validation of the pro-viral roles of TTC4 and HSP90 would be challenging to perform as small animal BoHV-1 model are limited to rabbits or immunocompromised mice [31,32] and large animal models are taxing for practical, financial, and ethical reasons. However, bovine lung and reproductive tract explants and in vitro neuronal models have previously been used to study BoHV-1 [24,28,33,34], and this would be valuable future work. Another barrier to the therapeutic use of HSP90 inhibitors is the development of a product accessible to the veterinary market.…”
Section: Discussionmentioning
confidence: 99%